Table 2.
Surgical method | P | ||
---|---|---|---|
SITU-LRYGB (n = 25) | 5-port LRYGB (n = 25) | ||
Gendera | 0.059 | ||
Female | 21 (84.0%) | 15 (60.0%) | |
Male | 4 (16.0%) | 10 (40.0%) | |
Age (years)b | 29.88 ± 6.28 | 29.88 ± 6.43 | 1.000 |
Height (cm)b | 163.42 ± 5.91 | 167.27 ± 10.73 | 0.125 |
Weight (kg)b | 112.42 ± 17.39 | 127.93 ± 25.58 | 0.016* |
BMI (kg/m2)b | 41.91 ± 5.09 | 45.31 ± 5.33 | 0.026* |
Comorbid conditions | |||
Hyperlipidemiaa | 11 (44.0%) | 8 (32.0%) | 0.560 |
Nonalcoholic steatohepatitisa | 8 (32.0%) | 14 (56.0%) | 0.154 |
Hypertensiona | 5 (20.0%) | 11 (44.0%) | 0.130 |
Diabetes mellitusa | 5 (20.0%) | 3 (12.0%) | 0.700 |
Hyperuricemiaa | 4 (16.0%) | 6 (24.0%) | 0.724 |
Gallstonesc | 1 (4.0%) | 1 (4.0%) | 0.470 |
Osteoarthritisc | 1 (4.0%) | 0 (0.0%) | 1.000 |
Continuous variables were presented as mean ± standard deviation and categorical variables were presented as number (percent)
SITU single-incision transumbilical
*P < 0.05 (statistically significant difference between the two groups)
a P values were calculated by chi-square test
b P values were calculated by independent t test
c P values were calculated by Fisher’s exact test